2023
DOI: 10.1016/j.heliyon.2023.e17601
|View full text |Cite
|
Sign up to set email alerts
|

Triethylammonium salt of a synthesized dicoumarol: Structural insight and human anti-glioblastoma activities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 41 publications
(49 reference statements)
0
1
0
Order By: Relevance
“…Additional chemotherapeutic alternatives for GBM include anti-angiogenic medicines such as tyrosine kinase inhibitors, anti-VEGF monoclonal antibodies, anti-FGF antibodies, and monoclonal antibodies targeting EGFR (Erlotinib and Gefitinib). 37,38…”
Section: Different Treatments For Glioblastomamentioning
confidence: 99%
“…Additional chemotherapeutic alternatives for GBM include anti-angiogenic medicines such as tyrosine kinase inhibitors, anti-VEGF monoclonal antibodies, anti-FGF antibodies, and monoclonal antibodies targeting EGFR (Erlotinib and Gefitinib). 37,38…”
Section: Different Treatments For Glioblastomamentioning
confidence: 99%